When is the optimal time to use PARP inhibitors in prostate cancer patients?
How doctors can address the issue of smoking and changes in policy needed in European countries
The role of chemotherapy and immunotherapy in CRPC
Symptom control in advanced cancer - key issues and what we can do about it
The risks of combining therapies in renal cell carcinoma and bladder cancer